Evidence map›Paper›PMID 36499428›Full record

ArticleInternational journal of molecular sciences2022

Human β-Defensin 3 Inhibits

Erika Inoue, Shiyo Minatozaki, Yui Katsuta, Saori Nonaka, Hiroshi Nakanishi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Noradrenaline Synergistically EnhancesInternational journal of molecular sciences · 2025
    Article
  4. Alzheimer's Disease andLife (Basel, Switzerland) · 2025
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Erika InoueFaculty of Pharmacy, Yasuda Women's University, Hiroshima 731-0153, Japan.
Shiyo MinatozakiFaculty of Pharmacy, Yasuda Women's University, Hiroshima 731-0153, Japan.
Yui KatsutaFaculty of Pharmacy, Yasuda Women's University, Hiroshima 731-0153, Japan.
Saori NonakaDepartment of Pharmacology, Faculty of Pharmacy, Yasuda Women's University, Hiroshima 731-0153, Japan.
Hiroshi NakanishiDepartment of Pharmacology, Faculty of Pharmacy, Yasuda Women's University, Hiroshima 731-0153, Japan.
Yasuda Women's University · JP

Funding

Japan Society for the Promotion of Science JP21K06383 (HN); JP22K15287(SN)the Science Research Promotion Fund from Promotion and Mutual Aid Cooperation for Private School of Japan 2021-2022
6 · The paper itself

Abstract

Recently, the effects of antibacterial peptides are suggested to have therapeutic potential in Alzheimer's disease. Furthermore, systemic treatment of

Indexed as

Alzheimer Diseasebeta-DefensinsAnimalsCathepsin BCathepsin LHumansInterleukin-6LipopolysaccharidesMiceMicrogliaNF-kappa BPorphyromonas gingivalisbeta-DefensinsCathepsin BCathepsin LInterleukin-6LipopolysaccharidesNF-kappa Bantibacterial peptidecathepsin Bcathepsin Lhuman β-defensinsinterleukin-6lipopolysaccharidemicrogliaNF-κB p65nitric oxidePorphyromonas gingivalis

Identifiers

PMID36499428
PMCPMC9738813
OpenAlexW4311092574

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.